Cytosorbents (CTSO) Gains from Investment Securities (2014 - 2017)
Cytosorbents' (CTSO) quarterly Gains from Investment Securities came in at -$618248.0 in Q2 2017, down 424.52% on a YoY basis from $190513.0 in Q2 2016, and down 320.98% quarter-over-quarter from -$146858.0 in Q1 2017.
Powered by 
Analysis
Cytosorbents (CTSO) Gains from Investment Securities (2014 - 2017) Analysis & Trends
Cytosorbents (CTSO) has reported Gains from Investment Securities for 4 consecutive years, with -$618248.0 the latest figure, recorded in Q2 2017.
- For the quarter ending Q2 2017, Gains from Investment Securities fell 424.52% year-over-year to -$618248.0; the trailing twelve-month figure through Jun 2017 stood at -$761907.0 (down 283.22% YoY), and the FY2016 full-year result was $175418.0, up 113.04% from the prior year.
- Gains from Investment Securities fell to -$618248.0 in Q2 2017 per CTSO's latest filing, from -$146858.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $2.3 million in Q4 2014 and bottomed at -$3.6 million in Q2 2015.
- Historically, Gains from Investment Securities has averaged $13108.6 across 4 years, with a median of -$82576.0 in 2016.
- The widest YoY moves for Gains from Investment Securities: up 735.02% in 2015, down 1149.5% in 2015.
- Over 4 years, Gains from Investment Securities stood at $2.3 million in 2014, then slumped by 122.68% to -$527712.0 in 2015, then climbed by 6.88% to -$491397.0 in 2016, then slipped by 25.81% to -$618248.0 in 2017.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered -$618248.0, -$146858.0, and -$491397.0 for Q2 2017, Q1 2017, and Q4 2016 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | -618,248.00 |
| Mar 31, 2017 | -146,858.00 |
| Dec 31, 2016 | -491,397.00 |
| Sep 30, 2016 | 494,596.00 |
| Jun 30, 2016 | 190,513.00 |
| Mar 31, 2016 | -18,294.00 |
| Dec 31, 2015 | -527,712.00 |
| Sep 30, 2015 | 771,328.00 |
| Jun 30, 2015 | -3.60 Mn |
| Mar 31, 2015 | 2.01 Mn |
| Dec 31, 2014 | 2.33 Mn |
| Sep 30, 2014 | -234,600.00 |
| Jun 30, 2014 | 342,720.00 |
| Mar 31, 2014 | -316,200.00 |